Designed multiple ligands. An emerging drug discovery paradigm

被引：1086

作者：

Morphy, R ^{[1
]}

Rankovic, Z ^{[1
]}

机构：

[1] Organon Labs, Med Chem Dept, Newhouse ML1 5SH, Lanark, Scotland

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 21期

关键词：

D O I：

10.1021/jm058225d

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：6523 / 6543

页数：21

共 105 条

[61] The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist [J].

Macor, JE ;

Gurley, D ;

Lanthorn, T ;

Loch, J ;

Mack, RA ;

Mullen, G ;

Tran, O ;

Wright, N ;

Gordon, JC .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (03) :319-321

[62] Biphenyl derivatives as novel dual NK1/NK2-receptor antagonists [J].

Mah, R ;

Gerspacher, M ;

von Sprecher, A ;

Stutz, S ;

Tschinke, V ;

Anderson, GP ;

Bertrand, C ;

Subramanian, N ;

Ball, HA .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (16) :2065-2068

[63] Synthesis and SAR of 4-(1H-benzimidazole-2-carbonyl)piperidin with dual histamine H1/tachykinin NK1 receptor antagonist activity [J].

Maynard, GD ;

Bratton, LD ;

Kane, JM ;

Burkholder, TP ;

Santiago, R ;

Stewart, KT ;

Kudlacz, EM ;

Shatzer, SA ;

Knippenberg, RW ;

Farrell, AM ;

Logan, DE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (22) :2819-2824

[64] Studies toward the discovery of the next generation of antidepressants.: 3.: Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines [J].

Mewshaw, RE ;

Zhou, DH ;

Zhou, P ;

Shi, XJ ;

Hornby, G ;

Spangler, T ;

Scerni, R ;

Smith, D ;

Schechter, LE ;

Andree, TH .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (15) :3823-3842

[65] Studies toward the discovery of the next generation of antidepressants.: Part 2:: Incorporating a 5-HT1A antagonist component into a class of serotonin reuptake inhibitors [J].

Mewshaw, RE ;

Meagher, KL ;

Zhou, P ;

Zhou, DH ;

Shi, XJ ;

Scerni, R ;

Smith, D ;

Schechter, LE ;

Andree, TH .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (03) :307-310

[66] SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF A-80426 - A PUTATIVE NOVEL ANTIDEPRESSANT COMBINING ALPHA-2 ANTAGONISM WITH 5-HT UPTAKE INHIBITION [J].

MEYER, MD ;

HANCOCK, AA ;

TIETJE, K ;

SIPPY, KB ;

GIARDINA, WJ ;

KERWIN, JF .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (19) :2287-2292

[67] Structure-activity studies for a novel series of N-(arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamines possessing dual 5-HT uptake inhibiting and alpha(2)-antagonistic activities [J].

Meyer, MD ;

Hancock, AA ;

Tietje, K ;

Sippy, KB ;

Prasad, R ;

Stout, DM ;

Arendsen, DL ;

Donner, BG ;

Carroll, WA .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (07) :1049-1062

[68] Design and synthesis of novel PPARα/γ/δ triple activators using a known PPARα/γ dual activator as structural template [J].

Mogensen, JP ;

Jeppesen, L ;

Bury, PS ;

Pettersson, I ;

Fleckner, J ;

Nehlin, J ;

Frederiksen, KS ;

Albrektsen, T ;

Din, N ;

Mortensen, SB ;

Svensson, LA ;

Wassermann, K ;

Wulff, EM ;

Ynddal, L ;

Sauerberg, P .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (02) :257-260

[69] Guanidinium and aminoimidazolinium derivatives of N-(4-piperidyl)propanamides as potential ligands for μ opioid and I2-imidazoline receptors:: Synthesis and pharmacological screening [J].

Montero, A ;

Goya, P ;

Jagerovic, N ;

Callado, LF ;

Meana, JJ ;

Girón, R ;

Goicoechea, C ;

Martín, MI .

BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (04) :1009-1018

[70] From magic bullets to designed multiple ligands [J].

Morphy, R ;

Kay, C ;

Rankovic, Z .

DRUG DISCOVERY TODAY, 2004, 9 (15) :641-651

← 2 3 4 5 6 7 8 9 10 11 →